Mereo BioPharma (MREO) Other Non-Current Assets (2023 - 2026)
Mereo BioPharma (MREO) reported Other Non-Current Assets of $387000.0 for Q1 2026, up 1.84% year-over-year from $380000.0 in Q1 2025, and down 2.03% quarter-over-quarter from $395000.0 in Q4 2025.
Mereo BioPharma (MREO) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Other Non-Current Assets data on file, last reported at $387000.0 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $387000.0, up 1.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $387000.0 (up 1.84% YoY), and the FY2025 annual result was $395000.0, up 4.5% from the prior year.
- Other Non-Current Assets slipped to $387000.0 in Q1 2026 per MREO's latest filing, from $395000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $615000.0 in Q4 2023 and troughed at $378000.0 in Q4 2024.
- A 4-year average of $429222.2 and a median of $395000.0 in 2025 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets tumbled 38.54% in 2024, then advanced 4.5% in 2025.
- A 4-year view of Other Non-Current Assets shows it stood at $615000.0 in 2023, then plunged by 38.54% to $378000.0 in 2024, then rose by 4.5% to $395000.0 in 2025, then retreated by 2.03% to $387000.0 in 2026.
- Business Quant data shows MREO's Other Non-Current Assets at $387000.0 in Q1 2026, $395000.0 in Q4 2025, and $394000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | 387,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 387,000.00 |
| Dec 31, 2025 | 395,000.00 |
| Sep 30, 2025 | 394,000.00 |
| Jun 30, 2025 | 402,000.00 |
| Mar 31, 2025 | 380,000.00 |
| Dec 31, 2024 | 378,000.00 |
| Sep 30, 2024 | 437,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Dec 31, 2023 | 615,000.00 |